Form 4: Arcutis Biotherapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Larry Todd Edwards, SVP and Chief Commercial Officer of Arcutis Biotherapeutics, sold 3,725 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.
Summary
- Larry Todd Edwards, SVP and Chief Commercial Officer of Arcutis Biotherapeutics, sold 3,725 shares of common stock on October 2, 2024.
- The sale was executed to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $10.0122, with individual transactions ranging from $9.51 to $10.31.
- Following the transaction, Edwards directly owns 136,635 shares of Arcutis Biotherapeutics.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation for executives. This transaction is not necessarily indicative of the executive's view of the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of stock sale transaction |
| 10/03/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.